Orhan Altınyüzük
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Orhan Altınyüzük has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Bartu Ediz
Department of Nephrology Kartal Dr. Lütfi Kırdar Training and Research Hospital, University of Health Sciences Istanbul Turkey
2 shared publications - Ergün Parmaksız
Department of Nephrology Kartal Dr. Lütfi Kırdar Training and Research Hospital, University of Health Sciences Istanbul Turkey
2 shared publications - Serkan Feyyaz Yalin
Department of Nephrology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey
2 shared publications - Melike Hazal Umut1 shared publication
- Meral Meşe
University of Health Sciences, Kartal Dr Lütfi Kirdar Training Hospital
1 shared publication
Latest Publications
- Open Access
- 21 September 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (9) , e73580
Asymptomatic Medullary Thyroid Carcinoma With Isolated Carcinoembryonic Antigen Elevation in a Patient With Chronic Kidney Disease: A Case Report
Medullary thyroid carcinoma (MTC) is rare and typically presents with a palpable nodule. We report a 64‐year‐old asymptomatic woman with chronic kidney disease (CKD) diagnosed with MTC after incidental procalcitonin elevation on routine labs, highlighting procalcitonin as an atypical clue and the need to distinguish tumor‐related from CKD‐related hypercalcitoninemia.
- 21 September 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (9) , e73580
Open AccessAsymptomatic Medullary Thyroid Carcinoma With Isolated Carcinoembryonic Antigen Elevation in a Patient With Chronic Kidney Disease: A Case Report
Medullary thyroid carcinoma (MTC) is rare and typically presents with a palpable nodule. We report a 64‐year‐old asymptomatic woman with chronic kidney disease (CKD) diagnosed with MTC after incidental procalcitonin elevation on routine labs, highlighting procalcitonin as an atypical clue and the need to distinguish tumor‐related from CKD‐related hypercalcitoninemia.